Matches in Wikidata for { <http://www.wikidata.org/entity/Q66035273> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- Q66035273 description "clinical trial" @default.
- Q66035273 description "ensayu clínicu" @default.
- Q66035273 description "klinisch onderzoek" @default.
- Q66035273 description "клінічне випробування" @default.
- Q66035273 description "կլինիկական փորձարկում" @default.
- Q66035273 name "FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum" @default.
- Q66035273 name "FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum" @default.
- Q66035273 type Item @default.
- Q66035273 label "FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum" @default.
- Q66035273 label "FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum" @default.
- Q66035273 prefLabel "FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum" @default.
- Q66035273 prefLabel "FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum" @default.
- Q66035273 P1050 Q66035273-96FA1DA3-91AA-41CC-B16C-E846A31F6316 @default.
- Q66035273 P1132 Q66035273-4DC73F26-1177-44E8-8499-5BD7CE9B40BF @default.
- Q66035273 P1476 Q66035273-38304E70-5AE6-4CEE-96FE-49C1F1F2125B @default.
- Q66035273 P17 Q66035273-D07BD887-A8C9-4A62-B542-287FA66A70DE @default.
- Q66035273 P2899 Q66035273-B50B8CC8-C029-4A79-AA80-225F6A4927C2 @default.
- Q66035273 P3098 Q66035273-239471F8-C137-447F-B2B4-2ABA790156FB @default.
- Q66035273 P31 Q66035273-003B9D88-A014-471B-8692-2EE2A8584528 @default.
- Q66035273 P4844 Q66035273-72EBBD9F-85FB-40C6-8AFB-E5D031EAAC9E @default.
- Q66035273 P4844 Q66035273-78E3F13F-453E-4371-A348-CD5DBB626383 @default.
- Q66035273 P4844 Q66035273-A1430D9B-49A0-497A-8C03-55FF65A00F35 @default.
- Q66035273 P580 Q66035273-81BC4D13-131D-4AE9-9D47-9A7E2CB20271 @default.
- Q66035273 P582 Q66035273-58814772-F1EF-48CE-BF93-E526D66F30B5 @default.
- Q66035273 P6099 Q66035273-ABF3546C-E07B-4E40-B362-EF1244C218EC @default.
- Q66035273 P6153 Q66035273-2CA40D8C-A1C5-4903-8A55-C151D3699AC1 @default.
- Q66035273 P6153 Q66035273-5660CC53-D9FA-4B06-896B-FB5730D01AFB @default.
- Q66035273 P6153 Q66035273-7C1DD0FF-F2B5-4D13-A138-ADB87178340C @default.
- Q66035273 P6153 Q66035273-A3210B7A-67FD-4EDF-B0FC-F0A17A3E1A3A @default.
- Q66035273 P6153 Q66035273-BD0FA467-47F8-4A13-B426-39E2B6DD0615 @default.
- Q66035273 P6153 Q66035273-CD0B6B7D-C7E7-4FDF-9C05-F20B8DB190D4 @default.
- Q66035273 P6153 Q66035273-FE08F771-B35A-40E7-AE9A-C873383E8AE3 @default.
- Q66035273 P767 Q66035273-F82CFD45-1029-4EEB-A843-9F9728458B20 @default.
- Q66035273 P8363 Q66035273-8F7C01B4-A987-457D-AB20-20937BBDD244 @default.
- Q66035273 P921 Q66035273-D4487C8A-D5F8-4A18-AA96-6F45EA2C10A4 @default.
- Q66035273 P1050 Q356033 @default.
- Q66035273 P1132 "+238" @default.
- Q66035273 P1476 "A Phase II Trial Of Irinotecan /5-FU/ Leucovorin Or Oxaliplatin /5-FU / Leucovorin With And Without Cetuximab (C225) For Patients With Untreated Metastatic Adenocarcinoma Of The Colon or Rectum" @default.
- Q66035273 P17 Q30 @default.
- Q66035273 P2899 "+18" @default.
- Q66035273 P3098 "NCT00077233" @default.
- Q66035273 P31 Q30612 @default.
- Q66035273 P4844 Q412197 @default.
- Q66035273 P4844 Q413486 @default.
- Q66035273 P4844 Q422970 @default.
- Q66035273 P580 "2003-12-01T00:00:00Z" @default.
- Q66035273 P582 "2006-12-01T00:00:00Z" @default.
- Q66035273 P6099 Q42824827 @default.
- Q66035273 P6153 Q1799872 @default.
- Q66035273 P6153 Q1808012 @default.
- Q66035273 P6153 Q1950740 @default.
- Q66035273 P6153 Q30280268 @default.
- Q66035273 P6153 Q4897536 @default.
- Q66035273 P6153 Q6686580 @default.
- Q66035273 P6153 Q777403 @default.
- Q66035273 P767 Q266423 @default.
- Q66035273 P8363 Q78089383 @default.
- Q66035273 P921 Q18554959 @default.